Relevance of pheno- and genotyping in clinical drug development.

Abstract excerpt

Individual variability in the plasma concentration of a xenobiotic is a considerable problem in the clinical use as well as in the clinical development of a new drug. In clinics altered drug response and drug toxicity are predominant findings. In clinical development (especially in the early phases) problems with the interpretation of individual pharmacokinetics and appearance of unexpected drug reactions may...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Phenotype
• Share to Drug Design
• Share to Genotype